The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Biodegradable polyesters for medical and ecological applications
Ikada, Y., & Tsuji, H. (2000) · Macromolecular Rapid Communications · doi:10.1002/(sici)1521-3927(20000201)21:3<117::aid-marc117>3.0.co;2-x · Cited by 1,512
Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00127-x · Cited by 990
Gan, Q., Wang, T., Cochrane, C., & McCarron, P. (2005) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2005.06.001 · Cited by 908
Polysaccharide colloidal particles as delivery systems for macromolecules
Janes, K. A., Calvo, P., & Alonso, M. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00123-x · Cited by 900
Nonviral gene therapy: promises and challenges
Li, S., & Huang, L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301110 · Cited by 614
Effect of chitosan on epithelial permeability and structure
Dodane, V (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00030-7 · Cited by 578
Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles
Prabha, S., Zhou, W.-Z., Panyam, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00315-0 · Cited by 553
Zambaux, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00106-5 · Cited by 537
Panyam, J., Dali, M. M., Sahoo, S. K., Ma, W., Chakravarthi, S. S., Amidon, G. L., Levy, R. J., & Labhasetwar, V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00328-6 · Cited by 529
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution
Mainardes, R. M., & Evangelista, R. C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.027 · Cited by 494
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
Ravi Kumar, M. N. V., Bakowsky, U., & Lehr, C. M. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.069 · Cited by 492
Self-citationBiodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease
Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Maincent, P., Kawashima, Y., & Lehr, C.-M. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29290-9 · Cited by 403
Self-citationKöping-Höggård, M., Vårum, K., Issa, M., Danielsen, S., Christensen, B., Stokke, B., & Artursson, P. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302312 · Cited by 385
Chorny, M., Fishbein, I., Danenberg, H. D., & Golomb, G. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00211-0 · Cited by 370
Song, C. X., Labhasetwar, V, Murphy, H., Qu, X., Humphrey, W. R., Shebuski, R. J., & Levy, R. J. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01484-8 · Cited by 367
Ishida, T., Harada, M., Wang, X. Y., Ichihara, M., Irimura, K., & Kiwada, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.003 · Cited by 365
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method
Kwon, H.-Y., Lee, J.-Y., Choi, S.-W., Jang, Y., & Kim, J.-H. (2001) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(00)00825-6 · Cited by 286
Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers
Park, M. R., Han, K. O., Han, I. K., Cho, M. H., Nah, J. W., Choi, Y. J., & Cho, C. S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.008 · Cited by 236
Hama, S., Akita, H., Ito, R., Mizuguchi, H., Hayakawa, T., & Harashima, H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.10.007 · Cited by 211
siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene
Zhang, C., Tang, N., Liu, X., Liang, W., Xu, W., & Torchilin, V. P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.022 · Cited by 210
Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles
Dillen, K., Vandervoort, J., Van den Mooter, G., Verheyden, L., & Ludwig, A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.033 · Cited by 175
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha
Sánchez, A., Tobı́o, M., González, L., Fabra, A., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00019-8 · Cited by 162
Shakweh, M., Besnard, M., Nicolas, V., & Fattal, E. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.04.006 · Cited by 161
Bone tissue engineering by gene delivery
KOFRON, M., & LAURENCIN, C. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.008 · Cited by 151
Inhibition of human telomerase by 2′- O -methyl-RNA
Pitts, A. E., & Corey, D. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11549 · Cited by 144
Song, C. X., Labhasetwar, V. D., Cui, X., Underwood, T., & Levy, R. J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00016-9 · Cited by 144
Kim, T. H., Kim, S. I., Akaike, T., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.024 · Cited by 132
PLGA: Poloxamer and PLGA: Poloxamine blend nanostructures as carriers for nasal gene delivery
Csaba, N., Sánchez, A., & Alonso, M. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.017 · Cited by 120
Cationic Poly(lactide-co-glycolide) Nanoparticles as Efficient in vivo Gene Transfection Agents
Kumar, M. N. V. R., Mohapatra, S. S., Kong, X., Jena, P. K., Bakowsky, U., & Lehr, C. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2004.130 · Cited by 94
Self-citationElkharraz, K., Faisant, N., Guse, C., Siepmann, F., Arıca-Yegin, B., Oger, J.-M., Gust, R., Göpferich, A. M., Benoît, J., & Siepmann, J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.07.028 · Cited by 84
Cegnar, M., Premzl, A., Zavašnik‐Bergant, V., Kristl, J., & Kos, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.021 · Cited by 72
Nanoparticulate drug carriers based on hybrid poly(d,l-lactide-co-glycolide)-dendron structures
Costantino, L., Gandolfi, F., Bossy-Nobs, L., Tosi, G., Gurny, R., Rivasi, F., Vandelli, M. A., & Forni, F. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.04.026 · Cited by 68
Cardiovascular gene delivery: The good road is awaiting☆
Brewster, L. P., Brey, E. M., & Greisler, H. P. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.002 · Cited by 55
Release of DNA from dendriplexes encapsulated in PLGA nanoparticles
Ribeiro, S. J., Hussain, N., & Florence, A. T. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.036 · Cited by 54
Influence of the Homogenisation Procedure on the Physicochemical Properties of PLGA Nanoparticles
Vandervoort, J., Yoncheva, K., & Ludwig, A. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.1273 · Cited by 42
Dillen, K., Weyenberg, W., Vandervoort, J., & Ludwig, A. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.035 · Cited by 38
Targeted Therapy of DNA Tumor Virus-Associated Cancers Using Virus-Activated Transcription Factors
Lim, M. J., Min, S., Lee, J.-J., Kim, I. C., Kim, J. T., Lee, D. C., Kim, N.-S., Jeong, S., Kim, M. N., Kim, K. D., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.023 · Cited by 22
Cited by
Chitosan-based formulations for delivery of DNA and siRNA
Mao, S., Sun, W., & Kissel, T. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.08.004 · Cited by 968
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Vauthier, C., & Bouchemal, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9800-3 · Cited by 929
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
The application of carbon nanotubes in target drug delivery systems for cancer therapies
Zhang, W., Zhang, Z., & Zhang, Y. (2011) · Nanoscale Research Letters · doi:10.1186/1556-276x-6-555 · Cited by 511
Materials for non-viral intracellular delivery of messenger RNA therapeutics
Kauffman, K. J., Webber, M. J., & Anderson, D. G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.032 · Cited by 395
Metadata
- Authors
- Nafee, N., Taetz, S., Schneider, M., Schaefer, U. F., & Lehr, C.-M.
- Venue
- Nanomedicine: Nanotechnology, Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 3
- Issue
- 3
- Pages
- 173-183
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W1978410646
- Cited by
- 264
- References
- 39
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.